Application Notes

Articles

LC–MS/MS method to separate furosemide and its metabolite using three different columns: Kinetex 2.6 µm Biphenyl, Luna Omega 1.6 µm C18, and Luna Omega 1.6 µm Polar C18

LC–MS/MS Separation of Furosemide and its Metabolite Using the Kinetex ® 2.6 µm Biphenyl, Luna® Omega 1.6 µm C18, and Luna Omega 1.6 µm Polar C18 Columns

Luna Omega 1.6µm, 3µm, and 5µm HPLC/UHPLC columns culminate 20 years of technological prowess, advancements, and innovation.


Luna Omega C18 Application eBook

Easily determine the allowable adjustments that can be made to European Pharmacopoeia (EP) methods and find the right column for your method.

Allowable Adjustments to European Pharmacopoeia (EP) Methods

Quickly view allowable adjustments outlined by the United States Pharmacopeia (USP) and select the proper Phenomenex column for your monograph using this simple guide.


USP Allowable Adjustments Guide

Analysis of ABN7 test mix used to assess scalability for Luna Omega C18 columns across a range of particle sizes (1.6 µm, 3 µm, and 5 µm) in three different dimensions. 


Demonstrating Utility of the Phenomenex Online UHPLC/HPLC Method Transfer Tool Using the Luna Omega C18 Columns

Improve United States Pharmacopeia (USP) method performance with allowable adjustments

Pharmacopeia Application eBook for Small Molecule Analysis

 In this application note we demonstrate the excellent performance of Sapiens-624MS columns for the analysis of e-liquids based on ISO 20714.


Application Note : Analysis of e-liquids According to ISO 20714 

The fight against cancer employs many tools. Paclitaxel, a compound found in the bark of the Pacific yew tree, is one that that has been found to make a big difference.


Isolation of Paclitaxel v2

The pharma industry is embracing the challenge of sustainability by using greener solvents. A GC–MS method for analyzing 32 green solvents is presented.
 






Application Note: GC–MS Analysis of Volatile Green Residual Solvents

To monitor FcR receptor binding, a recombinant FcγRIIIa-ligand has been commercialized into TSKgel FcR-IIIA high-performance affinity chromatography (AFC) columns that separate antibodies based on affinity differences to FcγRIIIa.

Application Notes: Pharmaceuticals